Timothy Robinson

Timothy Robinson, MD, PhD, is an Assistant Professor of Therapeutic Radiology at Yale School of Medicine, specializing in blood cancers and central nervous system malignancies. He combines radiation therapy with immune-based treatments like CAR T-cell therapy, focusing on improving outcomes for patients with hematologic malignancies. His translational research explores how alternative splicing and DNA repair mechanisms in cancer cells contribute to resistance against therapies. Dr. Robinson completed his MD and PhD in molecular cancer biology at Duke University School of Medicine.

Education: MD and PhD from Duke University School of Medicine. Research interests include radiation therapy optimization for CAR T-cell therapy, patterns of treatment failure in lymphoma, and molecular mechanisms of therapeutic resistance. He leads the palliative inpatient consult service at Smilow Cancer Center and contributes to studies on radiation-induced cytopenias and immunotherapy combinations.

Publications highlight his work on bridging radiotherapy for CAR T-cell therapy, CNS failure patterns, and translational studies on splicing variants. Collaborations involve multi-institutional trials and proteogenomic analyses. His lab investigates mRNA splicing in cancer and its role in immune therapy resistance.